Therapy News and Research

RSS

NextImage completes acquisition of WorkWell

NextImage Medical, a leading provider of specialized cost containment services to the workers' compensation industry, today announced that it has completed the purchase of WorkWell, Inc. The individual company product lines will continue to operate under their respective names. Liz Griggs, Chairman and CEO of NextImage Medical, will become the CEO of the combined entity. The financial terms of the acquisition were not made public.

11 Mar 2014

Study examines long-term outcomes of patients treated in inpatient rehabilitation hospitals

A new study released today at a meeting of the American Medical Rehabilitation Providers Association (AMRPA) shows that patients treated in inpatient rehabilitation hospitals and units had better long-term clinical outcomes than those treated in nursing homes.

11 Mar 2014

Kindred Healthcare intends to undertake refinancing of existing secured indebtedness

Kindred Healthcare, Inc. today announced that it intends to undertake a refinancing of its existing secured indebtedness. The proposed refinancing would extend the maturity profile of the Company's long-term debt, increase total availability under the Company's secured facilities, improve pricing and provide additional covenant flexibility.

11 Mar 2014

MedVantx MedStart Connect program increases patient initiation of new prescriptions

New research presented today at the World Congress Summit to Improve Adherence and Enhance Patient Engagement by researchers from the University of Pittsburgh School of Pharmacy, finds that a unique generic medication sampling program, the MedVantx MedStart™ Connect program, implemented in the primary care physicians' office, led to significantly increased patient initiation of new prescriptions (primary adherence) as well as continued use of the medications (secondary adherence), and could possibly lead to savings for health plans.

11 Mar 2014

High antibody affinity identifies type 1 diabetes

LADA (latent autoimmune diabetes in adults) is a form of type 1 diabetes in adulthood. Like the childhood form, the insulin-producing beta cells of the pancreas are destroyed by the body's own immune system.

11 Mar 2014

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients.

11 Mar 2014

Novel treatment strategy during transplantation surgery could spare patients from rejection

Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UC San Francisco researchers to specifically weaken immune responses that target transplanted tissue has shown promise in controlled experiments on mice.

11 Mar 2014

Promethera Biosciences, EMD Millipore partner to develop ready-to-use microfluidic perfusion liver assay

Promethera Biosciences, a company that develops innovative therapies for the treatment of liver diseases, today announces a collaboration with EMD Millipore to develop an improved ready-to-use microfluidic perfusion liver assay. This new product is designed to perform more robust studies in pre-clinical toxicity and drug metabolism.

11 Mar 2014

Scientists discover new protein that drive metastasis of cancer cells

An international team of researchers led by scientists at The Wistar Institute have discovered and defined LIMD2, a protein that can drive metastasis, the process where tumors spread throughout the body.

11 Mar 2014

Harvard Review of Psychiatry provides updates on ASD research

Recent years have seen exciting progress in key areas of research on autism spectrum disorders (ASD): from possible genetic causes, to effective treatments for common symptoms and clinical problems, to promoting success for young people with ASD entering college. Updates on these and other advances in ASD research are presented in the March special issue of Harvard Review of Psychiatry.

10 Mar 2014

Study finds that older patients are undertreated

Older people globally are being denied proper access to cancer care, according to an editorial by Queen's University Belfast academic, Professor Mark Lawler of the Centre for Cancer Research and Cell Biology.

10 Mar 2014

A pill may provide hope to relapsed leukemia and lymphoma patients

A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports published online today in Blood, the journal of the American Society of Hematology.

10 Mar 2014

Regado receives Fast Track designation from FDA for REG1

Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.

10 Mar 2014

FDA accepts Lundbeck's carbamazepine NDA for review

Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.

10 Mar 2014

Antares Pharma announces launch of OTREXUP to Dermatologists

Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

10 Mar 2014

New research reveals how substance abuse problems take hold in returning veterans

Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30th Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with the goal of understanding how abuse problems take hold in returning veterans.

10 Mar 2014

Mainstay Medical initiates clinical trial to investigate ReActiv8 as treatment for adults with CLBP

Mainstay Medical today announced that it has secured approval from Ethics Committees in Australia to start a clinical trial of ReActiv8, its innovative implantable neurostimulation device for the treatment of people with Chronic Low Back Pain (CLBP). Recruitment of subjects for the trial has commenced at three clinical sites in Australia.

10 Mar 2014

Study: Stem cell transplant effective in halting degenerative disc disease of spine

Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans.

10 Mar 2014

Tucson offers unique form of hormone replacement therapy, SottoPelle

Dr. Frank Comstock, whose office is located at 6127 N. La Cholla, Suite 175, in Tucson, is now offering SottoPelle®, a unique form of hormone replacement therapy, developed by internationally recognized Gino Tutera M.D., F.A.C.O.G., as a solution for patients who struggle with hormone imbalance and well-being.

10 Mar 2014

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Leading digital medicines company Proteus Digital Health is partnering with Eastern Academic Health Science Network, The Northern Health Science Alliance and Oxford University, Oxford University Hospitals NHS Trust and Oxford Academic Health Science Network to bring digital health technology and global operations and manufacturing to the UK.

10 Mar 2014

Therapy News and Research

NextImage completes acquisition of WorkWell

Study examines long-term outcomes of patients treated in inpatient rehabilitation hospitals

Kindred Healthcare intends to undertake refinancing of existing secured indebtedness

MedVantx MedStart Connect program increases patient initiation of new prescriptions

High antibody affinity identifies type 1 diabetes

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Novel treatment strategy during transplantation surgery could spare patients from rejection

Promethera Biosciences, EMD Millipore partner to develop ready-to-use microfluidic perfusion liver assay

Scientists discover new protein that drive metastasis of cancer cells

Harvard Review of Psychiatry provides updates on ASD research

Study finds that older patients are undertreated

A pill may provide hope to relapsed leukemia and lymphoma patients

Regado receives Fast Track designation from FDA for REG1

FDA accepts Lundbeck's carbamazepine NDA for review

Antares Pharma announces launch of OTREXUP to Dermatologists

New research reveals how substance abuse problems take hold in returning veterans

Mainstay Medical initiates clinical trial to investigate ReActiv8 as treatment for adults with CLBP

Study: Stem cell transplant effective in halting degenerative disc disease of spine

Tucson offers unique form of hormone replacement therapy, SottoPelle

Proteus Digital Health teams up with leading organisations to bring digital health technology to the UK

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News